2 results match your criteria: "Institute of Addiction Disorders[Affiliation]"
Pharmacol Biochem Behav
October 1999
MCP Hahnemann University, Institute of Addiction Disorders, Department of Psychiatry, Philadelphia, PA 19102-1192, USA.
The research described here concerns the interaction between the environment (context), the organism, and the effects of opiates, focusing on how conditioning and contextual cues affect drug controlled behaviors. This analysis applies the powerful tool of drug discrimination to a respondent conditioning procedure (discriminated taste aversion, DTA). Data show that the use of DTA is feasible in that it is sensitive to morphine dose and saccharin concentration.
View Article and Find Full Text PDFBehav Pharmacol
March 1998
Allegheny University of the Health Sciences, Institute of Addiction Disorders, Department of Psychiatry, Philadelphia, PA 19102, USA.
This study compared the effects of (R)-methanandamide, an analog of the mammalian brain constituent anandamide, and delta-9-tetrahydrocannabinol on the open-field behavior of male Sprague-Dawley rats. Rats were individually housed with free access to food and water. Animals were treated with 0, 1, 3, and 5.
View Article and Find Full Text PDF